# McGrath Rentcorp: financial statements, quarterly

MGRC · Nasdaq · CIK 752714 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mgrc.md) · [Financials](/companies/mgrc/financials.md) · [Filings](/companies/mgrc/filings.md) · [Insiders](/companies/mgrc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mgrc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [244](/filings/0000950170-24-117031.md) | [222 d](/filings/0001193125-26-071463.md) | [188](/filings/0000950170-25-057987.md) | [213](/filings/0000950170-25-098322.md) | [267](/filings/0001193125-25-248724.md) | [244 d](/filings/0001193125-26-071463.md) | [195](/filings/0001193125-26-191431.md) | [236](/filings/0001193125-26-323614.md) | [256](/filings/0001193125-25-248724.md) | [257 d](/filings/0001193125-26-071463.md) | [199](/filings/0001193125-26-191431.md) | [221](/filings/0001193125-26-323614.md) |
| Cost of revenue | $m | [132](/filings/0000950170-24-117031.md) | [111 d](/filings/0001193125-26-071463.md) | [94.6](/filings/0000950170-25-057987.md) | [109](/filings/0000950170-25-098322.md) | [143](/filings/0001193125-25-248724.md) | [129 d](/filings/0001193125-26-071463.md) | [99.0](/filings/0001193125-26-191431.md) | [125](/filings/0001193125-26-323614.md) | [137](/filings/0001193125-25-248724.md) | [128 d](/filings/0001193125-26-071463.md) | [102](/filings/0001193125-26-191431.md) | [113](/filings/0001193125-26-323614.md) |
| Gross profit | $m | [112](/filings/0000950170-24-117031.md) | [110 d](/filings/0001193125-26-071463.md) | [93.3](/filings/0000950170-25-057987.md) | [103](/filings/0000950170-25-098322.md) | [124](/filings/0001193125-25-248724.md) | [115 d](/filings/0001193125-26-071463.md) | [96.4](/filings/0001193125-26-191431.md) | [111](/filings/0001193125-26-323614.md) | [119](/filings/0001193125-25-248724.md) | [129 d](/filings/0001193125-26-071463.md) | [96.9](/filings/0001193125-26-191431.md) | [108](/filings/0001193125-26-323614.md) |
| Selling, general and administrative | $m | [48.5](/filings/0000950170-24-117031.md) | [54.5 d](/filings/0001193125-26-071463.md) | [50.5](/filings/0000950170-25-057987.md) | [49.0](/filings/0000950170-25-098322.md) | [49.3](/filings/0001193125-25-248724.md) | [51.7 d](/filings/0001193125-26-071463.md) | [50.9](/filings/0001193125-26-191431.md) | [53.5](/filings/0001193125-26-323614.md) | [52.5](/filings/0001193125-25-248724.md) | [54.4 d](/filings/0001193125-26-071463.md) | [53.5](/filings/0001193125-26-191431.md) | [56.4](/filings/0001193125-26-323614.md) |
| Operating income | $m | [66.6](/filings/0000950170-24-117031.md) | [55.7 d](/filings/0001193125-26-071463.md) | [52.1](/filings/0000950170-25-057987.md) | [54.4](/filings/0000950170-25-098322.md) | [74.7](/filings/0001193125-25-248724.md) | [63.1 d](/filings/0001193125-26-071463.md) | [45.6](/filings/0001193125-26-191431.md) | [57.2](/filings/0001193125-26-323614.md) | [66.7](/filings/0001193125-25-248724.md) | [74.2 d](/filings/0001193125-26-071463.md) | [43.4](/filings/0001193125-26-191431.md) | [53.3](/filings/0001193125-26-323614.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [15.2](/filings/0000950170-24-117031.md) | [11.7 d](/filings/0001193125-26-071463.md) | [7.0](/filings/0000950170-25-057987.md) | [8.4](/filings/0000950170-25-098322.md) | [53.5](/filings/0001193125-25-248724.md) | [13.0 d](/filings/0001193125-26-071463.md) | [9.2](/filings/0001193125-26-191431.md) | [13.5](/filings/0001193125-26-323614.md) | [16.2](/filings/0001193125-25-248724.md) | [17.9 d](/filings/0001193125-26-071463.md) | [9.8](/filings/0001193125-26-191431.md) | [12.5](/filings/0001193125-26-323614.md) |
| Net income | $m | [40.4](/filings/0000950170-24-117031.md) | [32.0 d](/filings/0001193125-26-071463.md) | [22.8](/filings/0001193125-25-248724.md) | [20.6](/filings/0001193125-25-248724.md) | [149](/filings/0001193125-25-248724.md) | [38.9 d](/filings/0001193125-26-071463.md) | [28.2](/filings/0001193125-26-323614.md) | [36.0](/filings/0001193125-26-323614.md) | [42.3](/filings/0001193125-25-248724.md) | [49.8 d](/filings/0001193125-26-071463.md) | [27.0](/filings/0001193125-26-323614.md) | [33.7](/filings/0001193125-26-323614.md) |
| Diluted EPS | $ per share | [1.65](/filings/0000950170-24-117031.md) | not reported | [0.93](/filings/0000950170-25-057987.md) | [0.84](/filings/0000950170-25-098322.md) | [6.08](/filings/0001193125-25-248724.md) | not reported | [1.15](/filings/0001193125-26-191431.md) | [1.46](/filings/0001193125-26-323614.md) | [1.72](/filings/0001193125-25-248724.md) | not reported | [1.10](/filings/0001193125-26-191431.md) | [1.37](/filings/0001193125-26-323614.md) |
| Basic EPS | $ per share | [1.65](/filings/0000950170-24-117031.md) | not reported | [0.93](/filings/0000950170-25-057987.md) | [0.84](/filings/0000950170-25-098322.md) | [6.08](/filings/0001193125-25-248724.md) | not reported | [1.15](/filings/0001193125-26-191431.md) | [1.46](/filings/0001193125-26-323614.md) | [1.72](/filings/0001193125-25-248724.md) | not reported | [1.10](/filings/0001193125-26-191431.md) | [1.38](/filings/0001193125-26-323614.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.9](/filings/0000950170-23-055596.md) | [0.9](/filings/0000950170-25-023116.md) | [1.9](/filings/0000950170-24-048261.md) | [9.4](/filings/0000950170-24-086480.md) | [4.1](/filings/0000950170-24-117031.md) | [0.8](/filings/0001193125-26-071463.md) | [3.4](/filings/0000950170-25-057987.md) | [1.5](/filings/0000950170-25-098322.md) | [7.3](/filings/0001193125-25-248724.md) | [0.3](/filings/0001193125-26-323614.md) | [2.4](/filings/0001193125-26-191431.md) | [4.4](/filings/0001193125-26-323614.md) |
| Total assets | $m | [2,137](/filings/0000950170-23-055596.md) | [2,217](/filings/0000950170-25-023116.md) | [2,263](/filings/0000950170-24-048261.md) | [2,318](/filings/0000950170-24-086480.md) | [2,286](/filings/0000950170-24-117031.md) | [2,278](/filings/0001193125-26-071463.md) | [2,242](/filings/0000950170-25-057987.md) | [2,327](/filings/0000950170-25-098322.md) | [2,351](/filings/0001193125-25-248724.md) | [2,357](/filings/0001193125-26-323614.md) | [2,378](/filings/0001193125-26-191431.md) | [2,503](/filings/0001193125-26-323614.md) |
| Total liabilities | $m | [1,225](/filings/0000950170-23-055596.md) | [1,283](/filings/0000950170-25-023116.md) | [1,320](/filings/0000950170-24-048261.md) | [1,364](/filings/0000950170-24-086480.md) | [1,192](/filings/0000950170-24-117031.md) | [1,154](/filings/0001193125-26-071463.md) | [1,106](/filings/0000950170-25-057987.md) | [1,164](/filings/0000950170-25-098322.md) | [1,155](/filings/0001193125-25-248724.md) | [1,120](/filings/0001193125-26-323614.md) | [1,141](/filings/0001193125-26-191431.md) | [1,258](/filings/0001193125-26-323614.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [911](/filings/0000950170-24-117031.md) | [934](/filings/0001193125-26-071463.md) | [943](/filings/0001193125-25-248724.md) | [954](/filings/0001193125-25-248724.md) | [1,094](/filings/0001193125-25-248724.md) | [1,123](/filings/0001193125-26-323614.md) | [1,136](/filings/0001193125-26-323614.md) | [1,163](/filings/0001193125-26-323614.md) | [1,196](/filings/0001193125-25-248724.md) | [1,237](/filings/0001193125-26-323614.md) | [1,237](/filings/0001193125-26-323614.md) | [1,245](/filings/0001193125-26-323614.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.5 d](/filings/0000950170-24-117031.md) | [(23.6) d](/filings/0001193125-26-071463.md) | [59.4](/filings/0000950170-25-057987.md) | [79.2 d](/filings/0000950170-25-098322.md) | [199 d](/filings/0001193125-25-248724.md) | [36.8 d](/filings/0001193125-26-071463.md) | [53.9](/filings/0001193125-26-191431.md) | [55.8 d](/filings/0001193125-26-323614.md) | [65.1 d](/filings/0001193125-25-248724.md) | [80.9 d](/filings/0001193125-26-071463.md) | [42.4](/filings/0001193125-26-191431.md) | [63.3 d](/filings/0001193125-26-323614.md) |
| Capital expenditure | $m | [5.2 d](/filings/0000950170-24-117031.md) | [27.5 d](/filings/0001193125-26-071463.md) | [25.3](/filings/0000950170-25-057987.md) | [4.8 d](/filings/0000950170-25-098322.md) | [5.9 d](/filings/0001193125-25-248724.md) | [4.2 d](/filings/0001193125-26-071463.md) | [4.0](/filings/0001193125-26-191431.md) | [17.6 d](/filings/0001193125-26-323614.md) | [11.6 d](/filings/0001193125-25-248724.md) | [11.1 d](/filings/0001193125-26-071463.md) | [8.0](/filings/0001193125-26-191431.md) | [11.4 d](/filings/0001193125-26-323614.md) |
| Dividends paid | $m | [11.4 d](/filings/0000950170-24-117031.md) | [11.4 d](/filings/0001193125-26-071463.md) | [11.8](/filings/0000950170-25-057987.md) | [11.7 d](/filings/0000950170-25-098322.md) | [11.7 d](/filings/0001193125-25-248724.md) | [11.7 d](/filings/0001193125-26-071463.md) | [12.1](/filings/0001193125-26-191431.md) | [11.9 d](/filings/0001193125-26-323614.md) | [11.9 d](/filings/0001193125-25-248724.md) | [11.9 d](/filings/0001193125-26-071463.md) | [12.5](/filings/0001193125-26-191431.md) | [12.2 d](/filings/0001193125-26-323614.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [11.9](/filings/0001193125-26-191431.md) | [15.5 d](/filings/0001193125-26-323614.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.5](/filings/0000950170-23-055596.md) | [24.5](/filings/0000950170-24-048261.md) | [24.5](/filings/0000950170-24-086480.md) | [24.5](/filings/0000950170-24-117031.md) | [24.6](/filings/0000950170-25-057987.md) | [24.6](/filings/0000950170-25-098322.md) | [24.6](/filings/0001193125-25-248724.md) | [24.6](/filings/0001193125-26-191431.md) | [24.6](/filings/0001193125-26-323614.md) | [24.6](/filings/0001193125-25-248724.md) | [24.7](/filings/0001193125-26-191431.md) | [24.5](/filings/0001193125-26-323614.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,425,663 at 2026-07-28, from the cover of the [10-Q filed 2026-07-29](/filings/0001193125-26-323614.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.